CIBC BANK USA - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 48 filers reported holding REDHILL BIOPHARMA LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC BANK USA ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2019$73,000
-13.1%
12,0000.0%0.01%
-16.7%
Q3 2019$84,000
+7.7%
12,0000.0%0.01%
+9.1%
Q2 2019$78,000
-22.0%
12,0000.0%0.01%
-21.4%
Q1 2019$100,000
+49.3%
12,0000.0%0.01%
+27.3%
Q4 2018$67,000
-36.8%
12,0000.0%0.01%
-21.4%
Q3 2018$106,000
-38.0%
12,000
-40.0%
0.01%
-41.7%
Q2 2018$171,000
+66.0%
20,0000.0%0.02%
+71.4%
Q1 2018$103,000
+102.0%
20,000
+100.0%
0.01%
+133.3%
Q4 2017$51,00010,0000.01%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Broadfin Capital, LLC 717,203$9,962,0000.89%
BANK HAPOALIM BM 147,504$2,049,0000.48%
MENORA MIVTACHIM HOLDINGS LTD. 246,000$3,417,0000.19%
Family Management Corp 16,500$229,0000.13%
Orbimed Advisors 564,900$7,846,0000.09%
SABBY MANAGEMENT, LLC 63,800$888,0000.03%
INGALLS & SNYDER LLC 41,550$577,0000.03%
Candriam S.C.A. 71,267$992,0000.02%
MONETARY MANAGEMENT GROUP INC 3,000$42,0000.02%
D.A. DAVIDSON & CO. 26,500$368,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders